SESSION TITLE: COPD
SESSION TYPE: Original Investigation Slide
PRESENTED ON: Sunday, April 17, 2016 at 09:45 AM - 11:15 AM
PURPOSE: A subanalysis of TIOtropium Safety and Performance In Respimat (TIOSPIR) found different exacerbation profiles in patients with COPD enrolled in Asia vs the rest of the World (RoW). We aimed to determine whether the demographic characteristics of patients in China only vs RoW account for these differences.